Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy.

Literature DB >> 32811233

Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy.

Tamer A Othman¹, Jianying Zhang², Matthew Mei¹, Anthony S Stein¹, Stephen J Forman¹, Guido Marcucci¹, Vinod Pullarkat¹, Ibrahim Aldoss¹.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2020 PMID： 32811233 DOI： 10.1080/10428194.2020.1808213

Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

Review 1. An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia.

Authors: Tamer A Othman; Matthew E Tenold; Benjamin N Moskoff; Tali Azenkot; Brian A Jonas
Journal: Expert Rev Hematol Date: 2021-06-15 Impact factor: 2.819

1 in total